| CA19-9与胰腺癌放化疗之间的关系 |
| |
| 引用本文： | 邵银剑,王颖杰. CA19-9与胰腺癌放化疗之间的关系[J]. 中国医药导报, 2013, 10(23): 31-33 |
| |
| 作者姓名： | 邵银剑 王颖杰 |
| |
| 作者单位： | 邵银剑 (安徽医科大学,安徽合肥,230032)； 王颖杰 (解放军空军总医院肿瘤放疗科,北京,100142)； |
| |
| 摘 要： | CA19-9作为胰腺癌最常用的肿瘤标志物,在胰腺癌放化疗中扮演着重要作用。本文通过复习近期文献,旨在为CA19-9在胰腺癌放化疗中的变化以及CA19-9作为胰腺癌放化疗预后的预测因子做一综述：治疗前CA19-9水平升高的胰腺癌患者放化疗后大部分患者的CA19-9水平下降明显;治疗前高水平的CA19-9及治疗后CA19-9下降未达预定幅度的胰腺癌患者预后较差,但这种差异是否有统计学意义尚需进一步证实。
|
| 关 键 词： | 胰腺癌 放射治疗 化学治疗 肿瘤标志物 血清CA19-9 |
Relationship between serum CA 19-9 and chemotherapy and radiotherapy in patients with pancreatic cancer |
| |
| SHAO Yinjian,WANG Yingjie. Relationship between serum CA 19-9 and chemotherapy and radiotherapy in patients with pancreatic cancer[J]. China Medical Herald, 2013, 10(23): 31-33 |
| |
| Authors: | SHAO Yinjian WANG Yingjie |
| |
| Affiliation: | 1.Anhui Medical University,Anhui Province,Hefei 230032,China;2.Department of Oncological Radiotherapy,Air Force General Hospital,Beijing 100142,China |
| |
| Abstract: | The serum CA 19-9 plays an very important role in patients with pancreatic cancer as the most frequent tumor marker.This article aims to describe the change and the predictive value of serum CA19-9 in patients with pancreatic cancer treated with chemotherapy and radiotherapy.The patients with elevated pretreatment serum CA 199 often have a large reduction of serum CA 19-9 after chemotherapy and radiotherapy.The patients with elevated pre treatment serum CA 19-9 have a shorter overall survival time.The patients with serum CA 19-9 reduction did not achieve prospective reduction range after treatment,they also had a poor prognosis,but this difference has not been determined by statistics. |
| |
| Keywords: | Pancreatic cancer Radiotherapy Chemotherapy Tumor marker Serum CA19-9 |
| 本文献已被 维普 等数据库收录！ |
